Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Non-Current Assets (2020 - 2025)

Historic Non-Current Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $6.5 million.

  • Insight Molecular Diagnostics' Non-Current Assets fell 9008.45% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 9749.81%. This contributed to the annual value of $6.3 million for FY2024, which is 1633.55% up from last year.
  • Latest data reveals that Insight Molecular Diagnostics reported Non-Current Assets of $6.5 million as of Q3 2025, which was down 9008.45% from $6.7 million recorded in Q2 2025.
  • Insight Molecular Diagnostics' 5-year Non-Current Assets high stood at $127.4 million for Q2 2021, and its period low was $5.4 million during Q4 2023.
  • Its 5-year average for Non-Current Assets is $65.3 million, with a median of $65.4 million in 2024.
  • Per our database at Business Quant, Insight Molecular Diagnostics' Non-Current Assets soared by 18301.93% in 2021 and then plummeted by 9270.87% in 2023.
  • Quarter analysis of 5 years shows Insight Molecular Diagnostics' Non-Current Assets stood at $120.4 million in 2021, then crashed by 38.09% to $74.6 million in 2022, then crashed by 92.71% to $5.4 million in 2023, then grew by 16.34% to $6.3 million in 2024, then grew by 2.58% to $6.5 million in 2025.
  • Its Non-Current Assets was $6.5 million in Q3 2025, compared to $6.7 million in Q2 2025 and $7.2 million in Q1 2025.